Cancer Family
Malignant Head and Neck Neoplasm
CI-CAN-00000236Explore in graph →
1,432 active trials17 approved drugs142 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000236Explore in graph →
Clinical trials
5,449 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (629)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04830488 | Body Image After Head and Neck Cancer Treatment(BIHNC) | completed | N/A | 7 | Bethany RhotenOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT02777385 | Pembrolizumab in Combination With Cisplatin and Intensity Modulated Radiotherapy (IMRT) in Head and Neck Cancer | completed | Phase 2 | 80 | Dan ZandbergOTHER | 1 | Aug 1, 2024 | clinicaltrials |
| NCT01847326 |
| Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer |
| completed |
| Phase 1 |
| 48 |
| University of ChicagoOTHER |
| 1 |
| Jul 31, 2024 |
| clinicaltrials |
| NCT04472026 | AIM1: Adequate Selection of Patients for Thyroid Biopsy: Evaluation of a Shared Decision Making Conversation Aid | completed | N/A | 66 | University of FloridaOTHER | 1 | Jul 31, 2024 | clinicaltrials |
| NCT06529588 | Estimation of (suPAR) in Chronic Periodontitis With Post-radiotherapy on HNCs Patients(HNCs) | completed | — | 150 | Al-Maarif University CollegeOTHER | 1 | Jul 31, 2024 | clinicaltrials |
| NCT02776163 | Postoperative Concurrent Chemoradiotherapy in Treating Patients With High-Risk Salivary Gland Carcinomas | completed | Phase 2 | 107 | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityOTHER | 1 | Jul 30, 2024 | clinicaltrials |
| NCT02393690 | Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer | completed | Phase 2 | 60 | Academic and Community Cancer Research UnitedOTHER | 1 | Jul 26, 2024 | clinicaltrials |
| NCT04570839 | COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors. | completed | Phase 1 / Phase 2 | 48 | Compugen LtdINDUSTRY | 1 | Jul 18, 2024 | clinicaltrials |
| NCT05330169 | Hearing Impairment of Nasopharyngeal Carcinoma | completed | — | 200 | Guangxi Medical UniversityOTHER | 1 | Jul 17, 2024 | clinicaltrials |
| NCT01064479 | Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck | completed | Phase 2 | 123 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 16, 2024 | clinicaltrials |
| NCT02383927 | Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations | completed | Phase 2 | 63 | Kura Oncology, Inc.INDUSTRY | 10 | Jul 11, 2024 | clinicaltrials |
| NCT01856920 | QUILT-3.006 for Recurrent Medullary Thyroid Cancer | completed | Phase 2 | 35 | NantCell, Inc.INDUSTRY | 1 | Jul 9, 2024 | clinicaltrials |
| NCT03752398 | A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)(DUET-3) | completed | Phase 1 | 198 | Xencor, Inc.INDUSTRY | 1 | Jul 5, 2024 | clinicaltrials |
| NCT05915572 | Mulligan Technique on Shoulder Dysfunction | completed | N/A | 76 | Cairo UniversityOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT05538572 | A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors | completed | Phase 1 | 22 | Prelude TherapeuticsINDUSTRY | 2 | Jul 1, 2024 | clinicaltrials |
| NCT05578820 | Safety, Tolerability and Pharmacokinetics Investigation of Stimotimagene Copolymerplasmid | completed | Phase 1 | 21 | Gene Surgery LLCINDUSTRY | 1 | Jul 1, 2024 | clinicaltrials |
| NCT06481059 | suPAR is a Potential Biomarker of in Chronic Periodontitis Through the Impact of Post-radiotherapy on HNCs Patients(HNCs) | completed | — | 150 | Al-Maarif University CollegeOTHER | 1 | Jul 1, 2024 | clinicaltrials |
| NCT04541355 | Sodium Thiosulfate in Preventing Ototoxicity for Squamous Cell Cancer Patients Undergoing Chemoradiation With Cisplatin | completed | Phase 2 | 16 | Hyunseok Kang, MDOTHER | 1 | Jun 28, 2024 | clinicaltrials |
| NCT05557825 | The Use of Photobiomodulation in the Management of Radiodermatitis in Head and Neck Cancer Patients | completed | — | 3 | University of Nove de JulhoOTHER | 1 | Jun 28, 2024 | clinicaltrials |
| NCT06469892 | Saliva and Plasma Exosomes for Oral Leukoplakia Malignant Transformation Diagnosis and Oral Cancer Prognosis Monitoring | completed | — | 225 | Beijing Stomatological Hospital, Capital Medical UniversityOTHER | 1 | Jun 24, 2024 | clinicaltrials |
| NCT06471270 | Validation of Salivary Proteomic Biomarkers for Early Detection of Oral Cancer in Egyptian Population | completed | N/A | 100 | British University In EgyptOTHER | 1 | Jun 24, 2024 | clinicaltrials |
| NCT03719690 | Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy(AIM-HN/SEQ-HN) | completed | Phase 2 | 296 | Kura Oncology, Inc.INDUSTRY | 16 | Jun 21, 2024 | clinicaltrials |
| NCT02923258 | Postoperative CCRT With Docetaxel vs Cisplatin in High Risk Oral Cavity Cancer | completed | Phase 2 / Phase 3 | 224 | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityOTHER | 1 | Jun 20, 2024 | clinicaltrials |
| NCT04107103 | Nivolumab Plus Pemetrexed for Head and Neck Squamous Cell Carcinoma(NivoPlus) | completed | Phase 2 | 6 | AHS Cancer Control AlbertaOTHER | 1 | Jun 14, 2024 | clinicaltrials |
| NCT04782856 | Energy Metabolism in Thyroidectomized Patients | completed | Phase 2 | 13 | Virginia Commonwealth UniversityOTHER | 1 | Jun 14, 2024 | clinicaltrials |
| NCT05897983 | Tens and Rocabado Exercises on TMJ Dysfunction(TMJ) | completed | N/A | 72 | Cairo UniversityOTHER | 1 | Jun 14, 2024 | clinicaltrials |
| NCT04162431 | DOLPHIN-VIVO: Diagnosis Of LymPHoma IN Vivo (Ex Vivo Phase)(DOLPHIN-VIVO) | completed | — | 50 | University of ExeterOTHER | 1 | Jun 11, 2024 | clinicaltrials |
| NCT06446570 | Phase II Study of Durvalumab(MEDI4736) + Tremelimumab in Pulmonary Sarcomatoid Carcinoma | completed | Phase 2 | 18 | Seoul National University HospitalOTHER | 1 | Jun 6, 2024 | clinicaltrials |
| NCT06437873 | Long-term Survival Outcomes of Total Thyroidectomy and Radioactive Iodine Therapy in Unilateral T3/T4 FTC | completed | — | 2,957 | Dezhou Hospital Qilu Hospital of Shandong UniversityOTHER | 0 | May 31, 2024 | clinicaltrials |
| NCT03776123 | Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients | completed | — | 347 | IpsenINDUSTRY | 1 | May 29, 2024 | clinicaltrials |
| NCT06432244 | The Effect of the Number of Central Lymph Nodes on Changes in Parathyroid Function | completed | — | 2,000 | Shandong Provincial HospitalOTHER_GOV | 1 | May 29, 2024 | clinicaltrials |
| NCT06432257 | The Effect of the Application of Head Mounted Magnifying Glasses on Postoperative PTH Changes in Thyroid Surgery | completed | — | 2,000 | Shandong Provincial HospitalOTHER_GOV | 1 | May 29, 2024 | clinicaltrials |
| NCT06429514 | Study on the Mechanism of Ganoderma Lucidum Spore Powder in the Treatment of Depression | completed | N/A | 298 | Ling ZhiqiangOTHER | 1 | May 28, 2024 | clinicaltrials |
| NCT03629756 | A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies | completed | Phase 1 | 48 | Arcus Biosciences, Inc.INDUSTRY | 2 | May 24, 2024 | clinicaltrials |
| NCT06428994 | Risk for Subsequent Osteoradionecrosis in A Transferred Fibula Flap in Head and Neck Cancer Patients Undergoing Segmental Mandibulectomy: a Cohort Study | completed | — | 580 | Chang Gung Memorial HospitalOTHER | 1 | May 24, 2024 | clinicaltrials |
| NCT06423105 | Influencing Factors and Prediction Model of False-negative Central Lymph Nodes in Thyroid Cancer Patients | completed | — | 6,369 | Ningning RenOTHER_GOV | 0 | May 23, 2024 | clinicaltrials |
| NCT06399159 | Prediction of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma Based on Ultrasound and Cytological Images | completed | — | 1,500 | Nanchong Central HospitalOTHER_GOV | 1 | May 22, 2024 | clinicaltrials |
| NCT04604158 | Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients | completed | N/A | 38 | Gillian GreshamOTHER | 1 | May 21, 2024 | clinicaltrials |
| NCT05539144 | A New Delineation Approach for Oral Cavity, Oropharynx, Larynx and Hypopharynx in IMRT for Head and Neck Cancer | completed | N/A | 8 | Hebei Provincial Hospital of Traditional Chinese MedicineOTHER_GOV | 1 | May 17, 2024 | clinicaltrials |
| NCT04995185 | 18F-FMISO PET Guided Dose Escalation in Nasopharyngeal Carcinoma - a Feasibility and Planning Study | completed | N/A | 9 | National Cancer Centre, SingaporeOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT03575949 | Standard and Delayed FDG PET/CT After Chemoradiation Therapy in Assessing Patients With Metastatic Head and Neck Squamous Cell Cancer | completed | N/A | 14 | M.D. Anderson Cancer CenterOTHER | 1 | May 14, 2024 | clinicaltrials |
| NCT06413095 | PBI-MST-01 (NCT04541108) Substudy MSD-03: Intratumoral Microdosing of Pembrolizumab Alone and With MK-0482 or MK-4830 in HNSCC or STS | completed | Early Phase 1 | 13 | Presage BiosciencesINDUSTRY | 1 | May 14, 2024 | clinicaltrials |
| NCT04396886 | Bintrafusp Alfa in Previously Treated Patients With R/M Non-keratinizing NPC | completed | Phase 2 | 38 | The University of Hong KongOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT05864924 | A Phase 1 Study of BRG01 in Subjects With Relapsed/Metastatic Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma | completed | Phase 1 | 14 | BioSyngen Pte LtdINDUSTRY | 1 | May 8, 2024 | clinicaltrials |
| NCT02072148 | The Sinai Robotic Surgery Trial in HPV Positive Oropharyngeal Squamous Cell Carcinoma (SCCA) (SIRS TRIAL) | completed | N/A | 112 | Icahn School of Medicine at Mount SinaiOTHER | 1 | May 6, 2024 | clinicaltrials |
| NCT02778191 | Comparison of Concomitant Cisplatin Versus Carboplatin and 5-fluorouracil With Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma | completed | — | 413 | University Medical Center GroningenOTHER | 1 | May 6, 2024 | clinicaltrials |
| NCT03025958 | Radiation Plus Concurrent Nimotuzumab in Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma | completed | Phase 2 | 30 | Zhejiang Cancer HospitalOTHER | 1 | May 6, 2024 | clinicaltrials |
| NCT04398121 | NBI in Oral Cavity Cancer | completed | — | 49 | Region Örebro CountyOTHER | 1 | May 3, 2024 | clinicaltrials |
| NCT04567082 | Proteome- and Methylation Profiles in Oropharyngeal Cancer(PROMEO) | completed | — | 45 | Aalborg University HospitalOTHER | 1 | May 2, 2024 | clinicaltrials |
Data updated 24 days agoSource updated Aug 9, 2024source: clinicaltrials